CHI’s 11th Annual Discovery on Target
September 24-26, 2013
Discovery on Target
Boston, MA
http://www.discoveryontarget.com/
Cambridge Healthtech Institute will host its 11th Annual Discovery on Target meeting showcasing current and emerging “hot” targets for the pharmaceutical industry from September 24-26, 2013 in Boston, MA. Spanning three days, the meeting attracts 700+ attendees, composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations. The meeting is comprised of 12 meeting tracks which include Targeting Epigenetic Readers; Targeting Histone Methyltransferases; Next- Generation Histone Deacetylase Inhibitors; Targeting Histone Demethylases; GPCRBased Drug Discovery; GPCR-Targeted Therapeutics; Functional Genomics Screening Strategies; Novel Strategies for Kinase Inhibitors; Antibodies against Membrane Protein Targets, and Cardio-Metabolic Drug Targets. The 2013 event will offer 150+ scientific presentations across these 12 conference tracks and 10 pre-conference short courses, 30+ interactive breakout discussion groups, an exhibit hall of 30+ companies, and dedicated poster viewing and networking sessions. The 11th Annual Discovery on Target assembles an impressive group of 175+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.
